Pasar al contenido principal

Genetic, environmental and epigenetic factors in neuropsychiatric phenotypes

RYC2021-033573-I

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Desarrollar, Atraer y Retener Talento
Subprograma Subprograma Estatal de Incorporación
Convocatoria Ramón y Cajal
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Shared vulnerability and sex-dependent polygenic burden in psychotic disorders

  • Mitjans, Marina
  • Papiol, Sergi
  • Fatjó-Vilas, Mar
  • González-Peñas, Javier
  • Acosta-Díez, Miriam
  • Zafrilla-López, Marina
  • Costas, Javier
  • Arango, Celso
  • Vilella, Elisabet
  • Martorell, Lourdes
  • Moltó, M. Dolores
  • Bobes, Julio
  • Crespo-Facorro, Benedicto
  • González-Pinto, Ana
  • Fañanás, Lourdes
  • Rosa, Araceli
  • Arias, Bárbara
Evidence suggests a remarkable shared genetic susceptibility between psychiatric disorders. However, sex-dependent differences have been less studied. We explored the contribution of schizophrenia (SCZ), bipolar disorder (BD) and major depressive disorder (MDD) polygenic scores (PGSs) on the risk for psychotic disorders and whether sex-dependent differences exist (CIBERSAM sample: 1826 patients and 1372 controls). All PGSs were significantly associated with psychosis. Sex-stratified analyses showed that the variance explained in psychotic disorders risk was significantly higher in males than in females for all PGSs. Our results confirm the shared genetic architecture across psychotic disorders and demonstrate sex-dependent differences in the vulnerability to psychotic disorders., This research was funded by: i) the Institute of Health Carlos III through projects (PI17/01122, PI18/00467, PI20/01002, PI22/00431, PI21/00713, PI12/02111; PI12/01885; PS09/01052) and contract (CP20/00072 to MFV), co-funded by European Regional Development Fund (ERDF)/European Social Fund “Investing in your future”, ii) SAF2007–60086, iii) the Comissionat per a Universitats i Recerca del DIUE of the Generalitat de Catalunya (AGAUR: 2021SGR01093; 2021SGR00706; 2021SGR01475; 2017SGR444), iv) LaMarató TV3 (202203-30-31-32). Grants PID2022–139740OA-I00 and PID2021–1277760B-I00 funded by MICIU/AEI/10.13039/501100011033 and by FEDER, EU. MM was supported by Horizon 2020 Marie Sklodowska-Curie Individual Fellowship from the European Commission under grant agreement no. 841899 (GRASAD). This article is part of the grant RYC2021–033573-I funded by MICIU/AEI/10.13039/501100011033 and by the European Union “NextGenerationEU”/PRTR”. Founders had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Genotype-phenotype correlations and putative modifier genes in SYNGAP1 Encephalopathy

  • Aranda, Selena
  • Ribeiro-Constante, Juliana
  • Tristán-Noguero, Alba
  • Moreno-Ruiz, Nerea
  • Arenas, Concepción
  • Martínez Calvo, Fernando Francisco
  • Ibáñez-Micó, Salvador
  • Peña Segura, José Luis
  • Ramos-Fernández, José Miguel
  • Moyano Chicano, María del Carmen
  • Camino León, Rafael
  • Soto-Insuga, Víctor
  • González-Alguacil, Elena
  • Valera Dávila, Carlos
  • Fernández-Jaén, Alberto
  • Plans, Laura
  • Camacho, Ana
  • Visa-Reñé, Nuria
  • Martín-Tamayo Blázquez, María del Pilar
  • Paredes-Carmona, Fernando
  • Marti-Carrera, Itxaso
  • Ginot-Julià, Guillem
  • Hernández-Fabián, Aránzazu
  • Tomàs Daví, Meritxell
  • Casadesús Sànchez, Mercè
  • Cuesta Herraiz, Laura
  • Fuentes Pita, Patricia
  • Bermejo González, Teresa
  • O'Callaghan, Mar
  • Iglesias Santa Polonia, Federico Felipe
  • Cazorla, María Rosario
  • Ferrando Lucas, María Teresa
  • González-Meneses, Antonio
  • Sala-Coromina, Júlia
  • Macaya, Alfons
  • Lasa-Aranzasti, Amaia
  • Cueto-González, Anna Mª
  • Párraga, Francisca Valera
  • Plana, Jaume Campistol
  • Serrano, Mercedes
  • Alonso, Xenia
  • Valenzuela Palafoll, Maria Irene
  • Monteagudo, Eines
  • Alonso-Colmenero, Itziar
  • Sans Capdevila, Oscar
  • Casals, Ferran
  • Cormand, Bru
  • García-Cazorla, Ángeles
  • Bayés, Àlex
  • Mitjans, Marina
Synaptic Ras GTPase-Activating Protein 1 (SynGAP) is a key regulator of synaptic plasticity, neurodevelopment, and neuronal circuit function. It is encoded by the SYNGAP1 gene, in which de novo dominant pathogenic variants are a major cause of SYNGAP1 Encephalopathy, a rare neurodevelopmental disorder characterised by intellectual disability, epilepsy, autistic traits, and other clinical manifestations. While some genetic studies have reported genotype-phenotype correlations in this condition, our understanding of how specific genetic variants contribute to the heterogeneous clinical symptoms remain limited. Here, we analysed a cohort of 44 cases extensively characterised at the phenotypic level to investigate the impact of genetic variants in SYNGAP1 and in potentially modulatory genes on the clinical features of SYNGAP1 Encephalopathy. Our results include the identification of four previously unreported likely pathogenic SYNGAP1 variants associated with the disease. In our cohort, individuals carrying variants within the PH domain of SynGAP exhibit milder phenotypes compared with other patients. Finally, patients harbouring rare or low-frequency variants in SYNGAP1-related genes tend to present with higher global severity. Taken together, these findings suggest that the location of SYNGAP1 variants, together with additional genetic modifiers, may contribute to variability in clinical presentation and disease severity. Further studies in larger cohorts and functional validation are needed to refine genotype-phenotype correlations and to support the development of personalized management strategies., The authors declare that financial support was received for the research, authorship, and/or publication of this article. AG-C is supported by FI21/0073 and FI24/00469 “Instituto de Salud Carlos III (ISCIII)” and “Fondo Europeo de desarrollo regional (FEDER)”. AT-N was supported by a “Margarita Salas” contract from Next-Generation Europe and postdoc mobility grants “EMBO short exchange research” grant and “José Castillejo” grant. AB financial support was provided by: PID2024-160538OB-I00, PID 2021-124411OB-I00 and RTI 2018–097037-B-I00 (MINECO/MCI/AEI/FEDER, EU), Award AC17/00005 by ISCIII through AES2017 and within the NEURON framework, Ramón y Cajal Fellowship (RYC-2011-08391p), IEDI-2017-00822 and AGAUR (2017 SGR 1776 and 2021 SGR 01005). AB and AT-N thank the CERCA Programme/Generalitat de Catalunya for institutional support. NM-R was supported by grant 2021 FI_B_00296 from Agència de Gestió d'Ajuts Universitaris i de Recerca, Generalitat de Catalunya. AC-G is member of the European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability ERN-ITHACA, funded by the European Union, under the grant agreement N°101156387. The study was supported by the generous funding provided by the association of Spanish SYNGAP1-DEE families, SYNGAP1 España. AB and BC wish to thank support from the Spanish Red de Investigación RED2024–154082-T., Funding supporting this study was provided by the Spanish ‘Ministerio de Ciencia, Innovación y Universidades’, funded by MICIU/AEI/10.13039/501100011033/ and FEDER-EU (PID2021-1277760B-I00 and PID2024-158634OB-I00, to BC; PID2022-139740OA-I00 to MMi; PID2021-125106OB-C32 and PID2024-161190OB-C22 to FC), ‘Generalitat de Catalunya/AGAUR’ (2021-SGR-01093, to BC and MMi), ICREA Academia 2021 (to BC), and ‘Fundació La Marató de TV3′ (202218-31, to BC). This article is part of the grant RYC2021-033573-I funded by MCIN/AEI/10.13039/501100011033 and by the European Union “NextGenerationEU/PRTR”. SA is supported by a Juan de la Cierva fellowship from the Spanish Ministry of Science and Innovation (JDC2024-055161-I)., Peer reviewed